Therapeutic effects of faricimab on aflibercept-refractory age-related macular degeneration

Therapeutic effects of faricimab on aflibercept-refractory age-related macular degeneration

Abstract Though vascular endothelial growth factors (VEGF) and other proangiogenic factors, such as angiopoietins (Ang), may be involved in the development of neovascular age-related macular degeneration (nvAMD), only drugs that inhibit the VEGF family are available for the treatment. The newly appr...

Full description

Bibliographic Details
Main Authors: Ryosuke Tamiya, Masayuki Hata, Asako Tanaka, Memiri Tsuchikawa, Naoko Ueda-Arakawa, Hiroshi Tamura, Manabu Miyata, Ayako Takahashi, Ai Kido, Yuki Muraoka, Masahiro Miyake, Sotaro Ooto, Akitaka Tsujikawa
Format: Article
Language:English
Published: Nature Portfolio 2023-11-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-023-48190-6

Internet

https://doi.org/10.1038/s41598-023-48190-6

Similar Items